Industry Insights
Are Today’s Processes Efficient Enough For The Future Of Vaccine And Viral Vector Production?
Article | By Dr. Mats Lundgren, GE Healthcare Life Sciences

By recognizing the limitations of today’s production processes, the industry may be able to overcome the challenges, complexity, and high cost of manufacturing vaccines and viral vector-based therapies.

In-House Versus Outsource: A Decision-Making Guide
White Paper | By B. Rosenblatt, Ph.D., SME Biotech Consulting and D. Kenyon, Ph.D., Patheon

Biopharmaceutical executives must consider how outsourcing fits into their development and production strategy, as well as how to select the best CDMO partner for their business. Here’s a step-by-step guide to help make that decision.

FDA-Approved 3D Printed Drug Paves Path For Precision Care In Patients
White Paper | By Don Wetherhold, Aprecia Pharmaceuticals

3D printing allows drug companies to not only boost efficacy and adherence but also contribute to their brand longevity by expanding and capturing market share with other dosage form options. 

Optimize Single-Use Bioreactor For Adherent Cell Culture On Microcarriers
Application Note | Thermo Fisher Scientific

This study shows a process for scaling up Vero cell culture from static T-flasks and Thermo Scientific Nunc Cell Factory Systems to a stirred-tank system.

Label-Free Interaction Analysis With Biacore T200
GE Healthcare Life Sciences
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.